- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01412866
Electronic Decision Support Systems for Smokers With Severe Mental Illness
Study Overview
Status
Detailed Description
Up to 80% of Americans with serious mental illnesses (SMI; schizophrenia and severe mood disorders) smoke cigarettes, and most suffer related health consequences. Although combined treatment with medication and psychosocial therapy can help people with SMI to quit smoking, it is rarely used. Motivational interventions can enhance the use of combined treatment, but motivational interventions are expensive and unavailable. To fill this gap, Dartmouth and Thresholds investigators have developed an easy-to-use, web-based electronic decision support system (EDSS) that aims to educate and motivate smokers with SMI. Preliminary testing has demonstrated excellent usability and increased engagement in smoking cessation treatments.
One critical issue is the use of personalized health feedback. Motivational interventions for smoking cessation for smokers with SMI, including our EDSS, have included personal feedback from a breath monitor that measures carbon monoxide, a toxic component of cigarette smoke. Feedback regarding carbon monoxide is thought to motivate the user by personalizing the health risks of smoking. The carbon monoxide monitor is, however, expensive, difficult to implement, and largely unavailable in public mental health and primary care clinics. Further, research on use of carbon monoxide monitoring in the general population is equivocal. Another motivational strategy to personalize the negative health effects of smoking is a health checklist with feedback. Health checklists have been shown to be effective, are easy to use, have no expense, but have not been assessed separately from carbon monoxide monitor feedback among SMI smokers. Testing the effect of feedback from the health checklist compared to feedback from the carbon monoxide monitor is an essential next step in the development of this tool.
Aim 1. The investigators propose a randomized clinical trial among SMI smokers to assess whether the EDSS with carbon monoxide monitor and health-checklist feedback will lead to higher rates of initiation of smoking cessation treatment than the EDSS with health-checklist feedback alone.
Aim 1.a. To explore whether use of the EDSS with carbon monoxide monitor and health-checklist feedback leads to higher rates of the distal outcomes, days of smoking abstinence and Fagerstrom Dependence scores, than use of the EDSS with checklist feedback alone.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States
- Thresholds Psychiatric Rehabilitation Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adult age 18-75
- in treatment for severe mental illness,
- current smoker,
- physically able to use a computer
Exclusion Criteria:
- Using smoking cessation treatment in past month,
- substance dependence with current use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: EDSS with CO monitor
Web-based electronic decision support system (EDSS) with carbon monoxide (CO) monitor and health-checklist
|
Web-based electronic decision support system with CO feedback and health-checklist
|
Active Comparator: EDSS without CO monitor
Web-based electronic decision support system (EDSS) with health-checklist only
|
Web-based electronic decision support system (EDSS) with health-checklist feedback alone (without CO feedback)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Initiation of Smoking Cessation Treatment
Time Frame: 2 months
|
Started smoking cessation treatment
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Days of Nicotine Abstinence
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mary F Brunette, MD, Dartmouth-Hitchcock Medical Center
Publications and helpful links
General Publications
- Brunette MF, Ferron JC, McHugo GJ, Davis KE, Devitt TS, Wilkness SM, Drake RE. An electronic decision support system to motivate people with severe mental illnesses to quit smoking. Psychiatr Serv. 2011 Apr;62(4):360-6. doi: 10.1176/ps.62.4.pss6204_0360.
- Ferron JC, Devitt T, McHugo GJ, A Jonikas J, Cook JA, Brunette MF. Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness. Community Ment Health J. 2016 May;52(4):446-56. doi: 10.1007/s10597-016-9998-1. Epub 2016 Mar 1.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EDSS1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Peking UniversityNot yet recruitingTreatment-resistant Schizophrenia
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
-
NYU Langone HealthNot yet recruitingTreatment-resistant SchizophreniaUnited States
Clinical Trials on EDSS with CO feedback and health checklist
-
Makerere UniversityCompletedSurgical Safety Checklist Compliance | Perioperative Surgical Adverse Events
-
Brock UniversityMitacsCompletedAnxiety Depression | Health Behavior | Work Related Stress | Job StressCanada
-
National Yang Ming UniversityNot yet recruitingStroke Syndrome
-
East Carolina UniversityMedical University of South Carolina; University of Florida; University of South...Enrolling by invitationDepression, Anxiety | Trauma, Psychological | Disruptive Behavior DisorderUnited States
-
Grand Valley State UniversitySpectrum Health HospitalsCompleted
-
Heinrich-Heine University, DuesseldorfCompletedShock | Intensive Care | MicrocirculationGermany
-
Amelia GulliverAustralian Institute of SportCompleted
-
Laval UniversityInstitut national en santé et services sociaux; Trauma Association of Canada; Health Standards Organisation and other collaboratorsNot yet recruiting
-
Tine De BurghraeveWithdrawnHeart Failure | Diabetes Mellitus | Chronic Kidney Diseases
-
University of WashingtonPatient-Centered Outcomes Research InstituteCompletedEnd Stage Liver Disease | Heart Failure | Critical Illness | Lung Neoplasms | Neoplasm Metastasis | Pulmonary Disease, Chronic Obstructive | Kidney Failure, Chronic | Communication | Chronic Disease | Palliative Care | Advance Care Planning | Terminal CareUnited States